WHSC News and 

WHSC News Releases for January


January 31, 2002 Winship Cancer Institute to Hold Hematology-Oncology Conference At The Cloisters at Sea Island
The Winship Cancer Institute at Emory University is preparing to host one of the most informative Hematology-Oncology Conferences in the Southeast. The meeting will take place July 13th through 17th, 2002, at The Cloisters, Sea Island, GA.

January 30, 2002 African Americans Have Special Reasons To Celebrate Black History and National Heart Month in February, Says Emory Heart Surgeon William Cooper
February is National Heart Month – a time to pay attention to cardiovascular health. It is also Black History month, the month-long celebration of the contributions made by African Americans to American science, culture, government and more. According to Emory Heart Center Cardiothoracic Surgeon William Cooper, MD, the fact both Heart Month and Black History Month occur at the same time is an opportunity to see the important relationship between the two subjects.

January 30, 2002 Unintended Pregnancies More Common for Adult Women Than Teenagers
Although a number of national efforts have been launched to reduce the number of teenage pregnancies, the most unintended and unwanted pregnancies occur in adults, says Emory University epidemiologist Carol Hogue, Ph.D., M.P.H., professor, Rollins School of Public Health.

January 30, 2002 Emory Heart Center Celebrates National Heart Month With Events To Promote Knowledge About Heart Health
As Valentine's Day approaches and thoughts turn to romance and paper hearts, the Emory Heart Center is encouraging people to think about their real hearts in February, by presenting eight Lunch and Learn lectures focused upon heart health.

January 30, 2002 March is Brain Awareness Month
A series of free public lectures during Brain Awareness Month in March will address fascinating topics covering the complex workings of the brain. Distinguished scientists from Emory University and Georgia State University will share their insights into three intriguing aspects of brain function during the three lectures sponsored by the Center for Behavioral Neuroscience (http://www.cbn-atl.org) and the Atlanta Chapter of the Society for Neuroscience.

January 30, 2002 Rollins Family Gives $4.2 Million to Establish New Office of Public Health Preparedness at Emory
A former assistant Surgeon General of the United States has been named to head a new program at Emory University that will address critical needs in the nation's public health system revealed by the terrorist attacks of last fall.

January 30, 2002 2000 Nobel Laureate Eric Kandel Will Deliver Breinin Lecture at Emory University
Eric Kandel, M.D., winner of the Nobel Prize in Physiology or Medicine in 2000 for his contributions to the fundamental processes of learning and memory, will deliver the annual Goodwin and Rose Helen Breinin Lecture in Basic Sciences at Emory University. The lecture will take place Thursday, Feb. 21 at 4:00 p.m. in the Woodruff Health Sciences Center Administration Building auditorium, located at 1440 Clifton Rd. on the Emory campus. A reception will immediately follow the lecture.

January 23, 2002 Counting Alleles Leads to Better Prognosis of Colorectal Cancer
A study by researchers at Emory University's Winship Cancer Institute (WCI) and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University identifies chromosomal imbalances as an accurate marker to predict recurrences of colorectal cancer. The study, "Counting Alleles to Predict Recurrence of Early Stage Colorectal Cancers," will be published in the January 19, 2002, issue of The Lancet.

January 23, 2002 Emory Physicians To Start First Hispanic Medical Clinic at Grady Hospital
Emory University physicians at Grady Memorial Hospital in Atlanta will open a General Medical Clinic for adult Latino patients in March, a first for Grady, which services a growing number of Spanish-speaking patients each year.

January 22, 2002 Reactive Oxygen Generated by NOX1 Enzyme Triggers Angiogenesis
An enzyme called Nox1, which converts oxygen into "reactive oxygen," is a potent trigger of angiogenesis, according to research by scientists at Emory University School of Medicine and Harvard Medical School. Angiogenesis is the growth of microscopic blood vessels that nourishes cancerous tumors and leads to unregulated cell growth. Reactive oxygen, which is created during cellular metabolism and includes molecules such as hydrogen peroxide, nitric oxide and superoxide, has long been implicated in causing cellular damage.

January 22, 2002 Emory Minimedical School 101 Returns
The popular Emory MiniMedical School 101 is back with new talks on the human brain and gastrointestinal system as well as lectures on the cardiovascular system, the nervous system, genetics, cancer, and other topics. Some of Emory's best known physicians and researchers, the very same people who teach regular medical students, explain the basic structure and function of organ systems and highlight exciting new advances in each field. Highly visual lectures are followed by lively and informative Q&A sessions. No science or medical background needed.

January 22, 2002 Migraine Headaches Can Decrease the Quality of Life For Some Perimenopausal Women
Hot flashes during menopause have become an expected, if not welcome, feature of middle age for many women. But few women are prepared for the increasing number of severe migraines that can signal menopause is in the offing (a period of time known as perimenopause).

January 18, 2002 Device to Treat Urinary Stress Incontinence Eliminates Need for Abdominal Incisions: Emory gynecologist one of two Georgia physicians using Capio CL device
Of the 13 million people in the United States who experience urinary incontinence, the vast majority are women. Stress urinary incontinence is the most common, but treatable, form of incontinence in women. It surfaces as a result of physical changes during pregnancy, childbirth, menopause or aging.

January 18, 2002 Emory Eye Center Pathologist Receives Teaching Grant for Internet Project
Hans E. Grossniklaus, MD, director of the L.F. Montgomery Eye Pathology Laboratory at the Emory Eye Center (EEC), has received Emory University's Teaching Fund (UTF) grant. Co-investigator of the grant and co-creator of the initiative is Daurice Grossniklaus, his wife. Preliminary findings from this initiative were presented at the American Association of Ophthalmic Pathologists in New Orleans in November 2001. This new award, together with two other grants he currently holds, provides Dr. Grossniklaus a total of $1,429,408 in grant money.

January 15, 2002 Bilateral Deep-Brain Stimulation Receives FDA Approval For Patients with Advanced Parkinson's Disease
The U.S. Food and Drug Administration (FDA) late yesterday approved a new form of treatment, using a so-called "brain pacemaker", for patients in the advanced stages of Parkinson's disease. In studies conducted at Emory University and 17 other locations, the treatment, known as bilateral deep-brain stimulation (DBS), has been shown to relieve slowness, stiffness and shaking that are associated with the debilitating disease. While the treatment moderates symptoms, it does not reverse the progression of the disease and is not a cure.

January 14, 2002 Media Advisory: "Celebrating Excellence in Our Youth: Making a Difference" 2002 Martin Luther King, Jr. Community Service Awards
Who: Emory University – Rollins School of Public Health, Nell Hodgson Woodruff School of Nursing, Goizueta Business School
When: Thursday, Jan. 24, 4:00 p.m.
Where: Nell Hodgson Woodruff School of Nursing Auditorium 1520 Clifton Rd., Atlanta

January 11, 2002 Alabama's Hazardous Calhoun County Draws Attention of Pediatric, Public Health Specialists from Emory University
Children at-risk in Alabama's Calhoun County are being targeted for an early detection/early intervention program that is being developed by the Southeast Pediatric Environmental Health Specialty Unit (PEHSU) at Emory University. The program will address the impact of the environment on the health and development of children in an area known for its widespread hazardous exposures.

January 11, 2002 Emory Scientists Develop Improved Protocol for Islet Cell Transplantation
New strategies being developed to treat diabetes by transplanting islet cells could be significantly advanced by using a newly engineered version of a molecule that blocks the immune system's ability to reject transplanted tissues. Transplant immunologists at Emory University School of Medicine were able to significantly prolong the survival of transplanted islet cells in rhesus monkeys by using this novel molecule, called LEA29Y, as part of an anti-rejection drug regimen. The research will be published in the journal Diabetes and was published in the online edition January 4, 2002.

January 11, 2002 FDA Panel Recommends Approval of Bone Growth Protein as Alternative to Bone Grafts in Spinal Fusion
An advisory panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval, with conditions, of a genetically engineered protein that stimulates the growth of bone cells and could provide a viable alternative to the painful bone grafts often used in spinal fusion surgery. If approved, the protein, called rhBMP-2 (recombinant human bone morphogenetic protein), would allow orthopaedic surgeons to use the body's own growth system to generate new bone following traumatic injury or disease.

January 2, 2002 Afraid of Heights? Emory Researchers May Have the Solution
Persons experiencing fear of heights (acrophobia) are being recruited for participation in a new combination virtual reality/drug study beginning at the Emory University School of Medicine.

For more general information on The Robert W. Woodruff Health Sciences
Center, call The Health Sciences Communications Office at
404-727-5686, or send e-mail to hsnews@emory.edu

Copyright Emory University, 2001. All Rights Reserved.